November 28, 2025 · Form 4 insider transaction
BENEVICH ERIC bought 5,970 shares of Neurocrine Biosciences, Inc. at $35.99 per share, a transaction worth $214.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Includes an aggregate of 204 shares purchased on February 28, 2025 and August 29, 2025 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.